Bnp Paribas Asset Management Holding S.A. Blueprint Medicines Corp Transaction History
Bnp Paribas Asset Management Holding S.A.
- $40.3 Billion
- Q4 2024
A detailed history of Bnp Paribas Asset Management Holding S.A. transactions in Blueprint Medicines Corp stock. As of the latest transaction made, Bnp Paribas Asset Management Holding S.A. holds 69,887 shares of BPMC stock, worth $5.83 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
69,887
Previous 69,887
-0.0%
Holding current value
$5.83 Million
Previous $6.47 Million
5.71%
% of portfolio
0.02%
Previous 0.02%
Shares
1 transactions
Others Institutions Holding BPMC
# of Institutions
384Shares Held
61.5MCall Options Held
1.6MPut Options Held
1.41M-
Vanguard Group Inc Valley Forge, PA6.77MShares$565 Million0.01% of portfolio
-
Black Rock Inc. New York, NY6.65MShares$554 Million0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD5.68MShares$474 Million0.06% of portfolio
-
State Street Corp Boston, MA2.5MShares$209 Million0.01% of portfolio
-
William Blair Investment Management, LLC Chicago, IL1.94MShares$162 Million0.44% of portfolio
About Blueprint Medicines Corp
- Ticker BPMC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,719,600
- Market Cap $4.98B
- Description
- Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...